Mom's Story, A Child Learns About MS

Mom's Story, A Child Learns About MS
Available on Amazon and www.marynickum.com

Saturday, December 10, 2022

New Advances in MS Treatment

Disease-modifying therapies (DMTs) can help decrease your MS symptoms. The FDA has approved new ones to treat and manage MS:

  • Diroximel fumarate (Vumerity) lessens inflammation and stops nerve damage that may cause MS symptoms.
  • Fingolimod (Gilenya) reduces the MS relapse rate in adults and children. It’s the first FDA-approved MS drug for kids. 
  • Ofatumumab (Kesimpta) is an injectable drug that can prevent MS symptoms from coming back and slow down disability in people with MS.

 More disease-modifying therapies (DMTs) the FDA has approved to treat and manage MS:

  • Ozanimod (Zeposia) can help with clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. 
  • Ponesimod (Ponvory) can lower MS symptoms coming back by more than 30%.
  • Siponimod (Mayzent) and cladribine (Mavenclad) are other MS treatments that can lower your relapse rate if you have MS. They stop certain cells of the immune system from causing nerve damage.

    health@messages.webmd.com

No comments:

Post a Comment